MicroRNA-101 inhibits invasion and angiogenesis through targeting ITGA3 and its systemic delivery inhibits lung metastasis in nasopharyngeal carcinoma

Cell Death and Disease

Volumn 8, Issue 1, 2017, Pages

  Tang, Xin Ran ^a   Wen, Xin ^a   He, Qing Mei ^a   Li, Ying Qin ^a   Ren, Xian Yue ^a   Yang, Xiao Jing ^a   Zhang, Jian ^a   Wang, Ya Qin ^a   Ma, Jun ^a   Liu, Na ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN AE1; CYTOKERATIN AE3; LENTIVIRUS VECTOR; MICRORNA 101; ALPHA3 INTEGRIN; ITGA3 PROTEIN, HUMAN; MICRORNA; MIRN101 MICRORNA, HUMAN;

5-8F CELL LINE; 6-10B CELL LINE; ADULT; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER PROGNOSIS; CANCER SURVIVAL; CELL MIGRATION; CHICKEN; CHORIOALLANTOIC MEMBRANE ASSAY; CNE-1 CELL LINE; CNE-2 CELL LINE; CONTROLLED STUDY; DISTANT METASTASIS; DISTANT METASTASIS FREE SURVIVAL; DOWN REGULATION; DRUG EFFICACY; DRUG MECHANISM; FEMALE; GENE OVEREXPRESSION; GENE TARGETING; HNE-1 CELL LINE; HONE-1 CELL LINE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; ITGA3 GENE; LUNG METASTASIS; LYMPH NODE METASTASIS; MALE; METASTASIS INHIBITION; MOUSE; NASOPHARYNGEAL CARCINOMA CELL LINE; NASOPHARYNX CARCINOMA; NONHUMAN; NP69SV40T CELL LINE; ONCOGENE; OVERALL SURVIVAL; PRIORITY JOURNAL; SUNE1 CELL LINE; TUMOR INVASION; VIRAL GENE DELIVERY SYSTEM; AGED; ANIMAL; BIOSYNTHESIS; CARCINOMA; CELL MOTION; CELL PROLIFERATION; DRUG SCREENING; GENE EXPRESSION REGULATION; GENETICS; LUNG NEOPLASMS; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; PATHOLOGY; SECONDARY; TUMOR CELL LINE;

ADULT; AGED; ANIMALS; CARCINOMA; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTEGRIN ALPHA3; LUNG NEOPLASMS; MALE; MICE; MICRORNAS; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; NEOPLASM INVASIVENESS; NEOVASCULARIZATION, PATHOLOGIC; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 85024488042     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2016.486     Document Type: Article

References (37)

1. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015; 65: 87-108.
2. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011; 61: 69-90.
3. Chua MLK, Wee JTS, Hui EP, Chan ATC. Nasopharyngeal carcinoma. Lancet 2016; 387: 1012-1024.
4. Lee AW, Ma BB, Ng WT, Chan AT. Management of nasopharyngeal carcinoma: current practice and future perspective. J Clin Oncol. 2015; 33: 3356-3364.
5. Chen L, Mao YP, Xie FY, Liu LZ, Sun Y, Tian L et al. The seventh edition of the UICC/AJCC staging system for nasopharyngeal carcinoma is prognostically useful for patients treated with intensity-modulated radiotherapy from an endemic area in China. Radiother Oncol. 2012; 104: 331-337.
6. Du XJ, Tang LL, Mao YP, Sun Y, Zeng MS, Kang TB et al. The pretreatment albumin to globulin ratio has predictive value for long-term mortality in nasopharyngeal carcinoma. PLoS One 2014; 9: e94473.
7. He L, Hannon GJ. MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet. 2004; 5: 522-531.
8. Baek D, Villen J, Shin C, Camargo FD, Gygi SP, Bartel DP. The impact of microRNAs on protein output. Nature 2008; 455: 64-71.
9. Bruce JP, Liu FF. MicroRNAs in nasopharyngeal carcinoma. Chin J Cancer 2014; 33: 539-544.
10. Kong YW, Ferland-McCollough D, Jackson TJ, Bushell M. microRNAs in cancer management. Lancet Oncol 2012; 13: e249-e258.
11. Ling H, Fabbri M, Calin GA. MicroRNAs and other non-coding RNAs as targets for anticancer drug development. Nat Rev Drug Discov 2013; 12: 847-865.
12. Liu N, Tang LL, Sun Y, Cui RX, Wang HY, Huang BJ et al. MiR-29c suppresses invasion and metastasis by targeting TIAM1 in nasopharyngeal carcinoma. Cancer Lett 2013; 329: 181-188.
13. Li YQ, Ren XY, He QM, Xu YF, Tang XR, Sun Y et al. MiR-34c suppresses tumor growth and metastasis in nasopharyngeal carcinoma by targeting MET. Cell Death Dis 2015; 6: e1618.
14. Xu YF, Mao YP, Li YQ, Ren XY, HeQM, Tang XR et al. MicroRNA-93 promotes cell growth and invasion in nasopharyngeal carcinoma by targeting disabled homolog-2. Cancer Lett 2015; 363: 146-155.
15. Liu N, Chen N-Y, Cui R-X, Li W-F, Li Y, Wei R-R et al. Prognostic value of a microRNA signature in nasopharyngeal carcinoma: a microRNA expression analysis. Lancet Oncol 2012; 13: 633-641.
16. Zweig MH, Campbell G. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem 1993; 39: 561-577.
17. Kota J, Chivukula RR, O'Donnell KA, Wentzel EA, Montgomery CL, Hwang HW et al. Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell 2009; 137: 1005-1017.
18. Jimenez-Mateos EM, Engel T, Merino-Serrais P, McKiernan RC, Tanaka K, Mouri G et al. Silencing microRNA-134 produces neuroprotective and prolonged seizure-suppressive effects. Nat Med 2012; 18: 1087-1094.
19. Chiou GY, Chien CS, Wang ML, Chen MT, Yang YP, Yu YL et al. Epigenetic regulation of the miR142-3p/interleukin-6 circuit in glioblastoma. Mol Cell 2013; 52: 693-706.
20. Bader AG. miR-34-a microRNA replacement therapy is headed to the clinic. Front Genet 2012; 3: 120.
21. Milena S, Nicoloso RS, Shimizu M, Rossi S, Calin GA. MicroRNAs-the micro steering wheel of tumour metastases. Nat Rev Cancer 2009; 9: 10.
22. Sun Q, Liu T, Zhang T, Du S, Xie GX, Lin X et al. MiR-101 sensitizes human nasopharyngeal carcinoma cells to radiation by targeting stathmin 1. Mol Med Rep 2015; 11: 3330-3336.
23. Li S, Fu H, Wang Y, Tie Y, Xing R, Zhu J et al. MicroRNA-101 regulates expression of the v-fos FBJ murine osteosarcoma viral oncogene homolog (FOS) oncogene in human hepatocellular carcinoma. Hepatology 2009; 49: 1194-1202.
24. Wang L, Zhang X, Jia LT, Hu SJ, Zhao J, Yang JD et al. c-Myc-mediated epigenetic silencing of MicroRNA-101 contributes to dysregulation of multiple pathways in hepatocellular carcinoma. Hepatology 2014; 59: 1850-1863.
25. Zheng F, Liao YJ, Cai MY, Liu TH, Chen SP, Wu PH et al. Systemic delivery of microRNA-101 potently inhibits hepatocellular carcinoma in vivo by repressing multiple targets. PLoS Genet 2015; 11: e1004873.
26. Alajez NM, Shi W, Hui AB, Bruce J, Lenarduzzi M, Ito E et al. Enhancer of Zeste homolog 2 (EZH2) is overexpressed in recurrent nasopharyngeal carcinoma and is regulated by miR-26a, miR-101, and miR-98. Cell Death Dis 2010; 1: e85.
27. Liu JJ, Lin XJ, Yang XJ, Zhou L, He S, Zhuang SM et al. A novel AP-1/miR-101 regulatory feedback loop and its implication in the migration and invasion of hepatoma cells. Nucleic Acids Res 2014; 42: 12041-12051.
28. Lin SC, Kao CY, Lee HJ, Creighton CJ, Ittmann MM, Tsai SJ et al. Dysregulation of miRNAs-COUP-TFII-FOXM1-CENPF axis contributes to the metastasis of prostate cancer. Nat Commun 2016; 7: 11418.
29. Flight MH. Trial watch: Clinical trial boost for lentiviral gene therapy. Nat Rev Drug Discov 2013; 12: 654.
30. Aiuti A, Biasco L, Scaramuzza S, Ferrua F, Cicalese MP, Baricordi C et al. Lentiviral hematopoietic stem cell gene therapy in patients with Wiskott-Aldrich syndrome. Science 2013; 341: 1233151.
31. Kingston RE, Chen CA, Okayama H. Calcium phosphate transfection. Curr Protoc Immunol 2001; Chapter 10: Unit 10.13. doi:10.1002/0471142735.im1013s31.
32. Mirshahi P, Rafii A, Vincent L, Berthaut A, Varin R, Kalantar G et al. Vasculogenic mimicry of acute leukemic bone marrow stromal cells. Leukemia 2009; 23: 1039-1048.
33. Xia Y, Cai XY, Fan JQ, Zhang LL, Ren JH, Chen J et al. Rho kinase inhibitor fasudil suppresses the vasculogenic mimicry of B16 mouse melanoma cells both in vitro and in vivo. Mol Cancer Ther 2015; 14: 1582-1590.
34. Prensner JR, Iyer MK, Sahu A, Asangani IA, Cao Q, Patel L et al. The long noncoding RNA SChLAP1 promotes aggressive prostate cancer and antagonizes the SWI/SNF complex. Nat Genet 2013; 45: 1392-1398.
35. Li Y, Kuscu C, Banach A, Zhang Q, Pulkoski-Gross A, Kim D et al. miR-181a-5p inhibits cancer cell migration and angiogenesis via downregulation of matrix metalloproteinase-14. Cancer Res 2015; 75: 2674-2685.
36. Xiao X, Zhou X, Ming H, Zhang J, Huang G, Zhang Z et al. Chick chorioallantoic membrane assay: a 3D animal model for study of human nasopharyngeal carcinoma. PLoS One 2015; 10: e0130935.
37. Liu N, Jiang N, Guo R, Jiang W, He Q-M, Xu Y-F et al. MiR-451 inhibits cell growth and invasion by targeting MIF and is associated with survival in nasopharyngeal carcinoma. Mol. Cancer 2013; 12: 8.